Navigation Links
Drug Safety Firm BioSoteria Receives Women's Business Enterprise Certification
Date:5/19/2010

BioSoteria, Inc., a drug safety services and education firm, has been certified as a Women’s Business Enterprise (WBE). Biopharmaceutical companies now have a choice in contracting with a certified WBE for drug safety advisement and operational support.

Emeryville, CA (PRWEB) May 19, 2010 -- BioSoteria, Inc., a drug safety services and education firm, announced today that it has been certified as a Women’s Business Enterprise (WBE) by the Women’s Business Enterprise National Council (WBENC).

The WBENC validates that a business is at least 51-percent owned, controlled, operated and managed by a woman or group of women. A woman owner or female designate must hold the highest office within the company, and the woman managing the day-to-day operations must possess industry expertise. With BioSoteria exceeding these requirements, Dr. Sally Van Doren, the firm’s Founder, President and CEO, pursued the WBE designation to further encourage women in leadership roles in the biopharmaceutical industry at large and in drug safety practice in particular
.
“Women comprise a large proportion of the pharmacovigilance workforce and have a vital role in promoting the safe use of pharmaceuticals,” said Dr. Van Doren. “I am pleased to offer biopharmaceutical companies the choice of contracting with a certified Women’s Business Enterprise to support their drug safety activities.”

To achieve WBE certification, BioSoteria completed an extensive application that required information on ownership, management, legal structure and financing. Once the documentation was reviewed, a formal site visit was administered by Astra Women’s Business Alliance, one of WBENC's fourteen Regional Partner Organizations. BioSoteria received its official certification earlier this month.

About the Women's Business Enterprise National Council (WBENC)
Founded in 1997, WBENC is the nation's leading advocate of women-owned businesses as suppliers to America's corporations and the largest third-party certifier of businesses owned, controlled, and operated by women in the United States. The 501(c)(3) non-profit engages Regional Partner Organizations to provide its national standard of certification to women-owned businesses throughout the country. For more information on WBENC, please visit the organization’s website at www.wbenc.org.

About BioSoteria
From strategic risk management consulting services and world-class pharmacovigilance training and education to full-service drug safety department capabilities, BioSoteria provides unmatched experience, expertise and leadership to support pharmaceutical and biotechnology companies’ efforts to maximize the benefit/risk balance of their products. To learn more about BioSoteria, please visit the company’s website at www.biosoteria.com, or call 1-866-660-5553.

###

Read the full story at http://www.prweb.com/releases/drugsafety/WBE/prweb4017604.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Brazilian National Biosafety Technical Committee Approves Monsanto Company Insect-Protected Corn Trait
2. Cardinal Health Establishes $1 Million Grant Fund for Initiatives That Improve Quality, Safety of Patient Care
3. Safety Profile of TAXUS(R) Liberte(TM) Stent System Highlighted in Worlds Largest Stent Registry
4. Circulation Publishes MERLIN TIMI-36 Data Showing Safety and Anti-Arrhythmic Effects of Ranexa(R)
5. Sigma-Aldrich and Lab Manager Magazine Present Webinar On Laboratory Environmental, Health and Safety Compliance Strategies
6. Biosafety and Biosecurity International Conference 2007 to be held in Abu Dhabi from November 12 to 14
7. Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiogaphic Data Safety Monitoring Board Review
8. Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiographic Data Safety Monitoring Board Review
9. Midwest Research Institute Launches Center for Biological Safety and Security (CBS2)
10. BioReliance Corporation Launches iNet(TM) for Online Results Tracking of Biological Safety Tests
11. Team demos safety of RNA therapy
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Drug Safety Firm BioSoteria Receives Women's Business Enterprise Certification 
(Date:6/27/2016)... 27, 2016  Liquid Biotech USA ... of a Sponsored Research Agreement with The University ... (CTCs) from cancer patients.  The funding will be ... correlate with clinical outcomes in cancer patients undergoing ... then be employed to support the design of ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... While the ... such as the Cary 5000 and the 6000i models are higher end machines that ... the height of the spectrophotometer’s light beam from the bottom of the cuvette holder. ...
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... and Mold) microbial test has received AOAC Research Institute approval 061601. , “This ... introduced last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. ...
Breaking Biology Technology:
(Date:4/14/2016)... 14, 2016 BioCatch ™, ... today announced the appointment of Eyal Goldwerger ... Goldwerger,s leadership appointment comes at a time ... the deployment of its platform at several of the ... which discerns unique cognitive and physiological factors, is a ...
(Date:3/31/2016)... 2016  Genomics firm Nabsys has completed a financial ... Bready , M.D., who returned to the company in ... leadership team, including Chief Technology Officer, John Oliver ... Nurnberg and Vice President of Software and Informatics, ... Dr. Bready served as CEO of Nabsys from ...
(Date:3/22/2016)... 2016 According to ... for Consumer Industry by Type (Image, Motion, Pressure, ... & IT, Entertainment, Home Appliances, & Wearable ... 2022", published by MarketsandMarkets, the market for ... USD 26.76 Billion by 2022, at a ...
Breaking Biology News(10 mins):